Current warnings week 13 - 2022
In March 2022, we tested a number of substances of particular health concern. In a ketamine sample, the new psychoactive substance Deoxymethoxetamine (DMXE) identified. A sample submitted as mephedrone (4-MMC) instead contained Clophedrone (3-CMC).
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings week 13-2022
Current warnings KW 11 - 2022
At the beginning of March 2022, we tested a number of substances of particular health concern. In addition to the expected MDMA, a tablet submitted for analysis as ecstasy also contained the new psychoactive substance Clephedrone (4-CMC) found. In two samples submitted as cannabis, the synthetic cannabinoid Cumyl-CH-MeGaClone identified.
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings KW 11-2022
Current warnings week 9 - 2022
At the end of February 2022, we tested a number of substances of particular health concern. In some samples submitted for analysis as cocaine, one or more extenders such as Levamisole detected. In two samples submitted as heroin, instead of the expected ingredients Caffeine, paracetamol and one unknown substance detected. And a sample submitted as cannabis contained a unknown substance.
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings KW 9-2022
Current warnings week 7 - 2022
In February 2022, we tested a number of substances of particular health concern. In a sample submitted as MDMA, the new psychoactive substance Pentylon was detected. One sample submitted as MMC contained instead 3-MeO-PCE. Two samples submitted as mephedrone (4-MMC) instead contained once Clophedrone (3-CMC) and once Clephedrone (4-CMC). In a hashish sample, the synthetic cannabinoid ADB-BUTINACA detected, one cannabis sample contained a unknown substance.
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings KW 7-2022
Current warnings week 5 - 2022
In January 2022, we tested a number of substances of particular health concern. Instead of MDMA, one ecstasy tablet contained Amphetamine and Caffeine. A sample passed off as LSD contained instead of LSD a unknown substance. A sample submitted as heroin showed two unknown substances .
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings KW 5-2022
Current warnings week 3 - 2022
In January 2022, we tested a number of substances of particular health concern. A powder dispensed as etizolam contained the long-acting benzodiazepine Flubromazepam. In a sample submitted as methamphetamine, the phenethylamine 2C-B proven.
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings KW 3-2022
Current warnings week 51-2021
In December 2021, we tested a number of substances of particular health concern. One sample submitted as speed did not contain the expected amphetamine but instead contained Methamphetamine. In an ecstasy tablet, instead of MDMA, the ingredients Domperidone, meta-chlorophenylpiperazine (mCPP) and Caffeine detected. On a cannabis sample a unknown substance proven.
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings week 51-2021
Current warnings week 49-2021
In November 2021, we tested a number of substances of particular health concern. One as 2C-B tablet showed besides 2C-B two unknown substances on. In several Ecstasy-pills, instead of MDMA, a unknown substance .
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings week 49-2021
Current warnings week 47-2021
In November 2021, we tested a number of substances of particular health concern. One tablet submitted for analysis as ecstasy contained Amphetamine and Caffeine identified. In addition to cocaine, some samples submitted as cocaine also contained Levamisole. A crystalline sample delivered as A-PHP (alpha-pyrrolidinohexiophenone) exhibited a unknown substance .
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings week 47-2021
Current warnings KW 45-2021
In October and early November 2021, we tested a number of substances of particular health concern. In addition to cannabis, three samples submitted as cannabis also contained the synthetic cannabinoid ADB-BUTINACA. In a sample submitted as mephedrone Clophedrone (3-CMC)in another sample submitted as mephedrone 3-Methylmethcathinone (3-MMC) was detected. One tablet dispensed as 2C-B showed 2-Br-4,5-DMPEA (6-Br-DMPEA) .
In the following, all samples that have been taken since the last warnings to date by checkit! analysed and classified as high-dose, unexpected or of particular health concern: Current warnings KW 45-2021